Axogen, Inc. (AXGN) Gross Margin
- Gross margin · 12 months: Value 74.56%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 74.56% | Gross profit / revenue. Period ending 2026-06-30. $187.26M ÷ $251.17M × 100 ≈ 74.56% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 187.26M USD | Gross Profit |
| Revenue | 251.17M USD | |
| Cost of products and services | 63.91M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $187.26M | $251.17M | $63.91M | 74.56% |
| 2026-03-31 | $178.61M | $238.10M | $59.50M | 75.01% |
| 2025-12-31 | $167.35M | $225.21M | $57.85M | 74.31% |
| 2025-09-30 | $160.52M | $214.71M | $54.19M | 74.76% |
| 2025-06-30 | $150.96M | $203.27M | $52.31M | 74.27% |
| 2025-03-31 | $144.29M | $194.52M | $50.23M | 74.18% |
| 2024-12-31 | $141.98M | $187.34M | $45.36M | 75.79% |
| 2024-09-30 | $142.43M | $180.85M | $38.43M | 78.75% |
| 2024-06-30 | $137.69M | $173.48M | $35.79M | 79.37% |
| 2024-03-31 | $132.00M | $163.73M | $31.72M | 80.62% |
| 2023-12-31 | $127.87M | $159.01M | $31.14M | 80.42% |
| 2023-09-30 | $124.13M | $152.25M | $28.12M | 81.53% |
| 2023-06-30 | $121.69M | $147.94M | $26.25M | 82.25% |
| 2023-03-31 | $118.93M | $144.24M | $25.31M | 82.45% |
| 2022-12-31 | $114.44M | $138.58M | $24.15M | 82.58% |
| 2022-09-30 | $110.52M | $133.96M | $23.43M | 82.51% |
| 2022-06-30 | $105.70M | $128.20M | $22.50M | 82.45% |
| 2022-03-31 | $104.02M | $127.33M | $23.30M | 81.70% |
| 2021-12-31 | $104.43M | $127.36M | $22.93M | 81.99% |
| 2021-09-30 | $105.35M | $128.32M | $22.97M | 82.10% |
| 2021-06-30 | $107.12M | $130.54M | $23.42M | 82.06% |
| 2021-03-31 | $97.14M | $119.08M | $21.94M | 81.58% |
| 2020-12-31 | $90.72M | $112.30M | $21.58M | 80.78% |
| 2020-09-30 | $86.97M | $107.97M | $21.00M | 80.55% |
| 2020-06-30 | $83.29M | $103.10M | $19.81M | 80.78% |
| 2020-03-31 | $89.24M | $107.69M | $18.45M | 82.87% |
| 2019-12-31 | $89.36M | $106.71M | $17.35M | 83.74% |
| 2019-09-30 | $85.87M | $101.98M | $16.11M | 84.20% |
| 2019-06-30 | $81.02M | $96.08M | $15.06M | 84.32% |
| 2019-03-31 | $76.04M | $89.96M | $13.93M | 84.52% |
| 2018-12-31 | $71.01M | $83.94M | $12.92M | 84.60% |
| 2018-09-30 | $65.58M | $77.48M | (m) | 84.64% |
| 2018-06-30 | $59.92M | $70.86M | (m) | 84.57% |
| 2018-03-31 | $55.34M | $65.45M | (m) | 84.55% |
| 2017-12-31 | $51.11M | $60.43M | (m) | 84.59% |
| 2017-09-30 | $46.34M | $54.86M | (m) | 84.46% |
| 2017-06-30 | $42.30M | $50.02M | (m) | 84.57% |
| 2017-03-31 | $38.26M | $45.24M | (m) | 84.58% |
| 2016-12-31 | $34.64M | $41.11M | (m) | 84.27% |
| 2016-09-30 | $31.46M | $37.51M | (m) | 83.86% |
| 2016-06-30 | $28.69M | $34.46M | (m) | 83.27% |
| 2016-03-31 | $25.22M | $30.49M | (m) | 82.71% |
| 2015-12-31 | $22.48M | $27.33M | (m) | 82.26% |
| 2015-09-30 | $19.93M | $24.32M | (m) | 81.95% |
| 2015-06-30 | $16.96M | $20.83M | (m) | 81.40% |
| 2015-03-31 | $14.91M | $18.63M | (m) | 80.01% |
| 2014-12-31 | $13.38M | $16.82M | (m) | 79.53% |
| 2014-09-30 | $11.93M | $15.01M | (m) | 79.47% |
| 2014-06-30 | $10.46M | $13.29M | (m) | 78.67% |
| 2014-03-31 | $9.36M | $11.94M | (m) | 78.39% |
| 2013-12-31 | $8.51M | $10.95M | (m) | 77.71% |
| 2013-09-30 | $7.69M | $10.01M | (m) | 76.79% |
| 2013-06-30 | $6.82M | $9.03M | (m) | 75.48% |
| 2013-03-31 | $6.10M | $8.18M | (m) | 74.54% |
| 2012-12-31 | $5.73M | $7.69M | (m) | 74.49% |
| 2012-09-30 | $4.99M | $7.01M | (m) | 71.23% |
| 2012-06-30 | $3.56M | $6.17M | (m) | 57.78% |
| 2012-03-31 | $2.85M | $5.38M | (m) | 53.04% |
| 2011-12-31 | $2.42M | $4.85M | (m) | 49.96% |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | $1.63M | $3.00M | (m) | 54.10% |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |